Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI to deploy the technology across its operations as it looks to keep pace with rapid expansion in the obesity drug market. The Danish company announced in a statement on Tuesday that it would use AI to analyze complex datasets, identify promising drug candidates…
Politics
·
Novo Nordisk partners with OpenAI in weight loss drug race
CN
CitrixNews Staff
Originally reported by The Hill
Related Articles
Politics
The filibuster has long forced senators to compromise. Can it survive 2026?
Politics The filibuster has long forced senators to compromise. Can it survive 2026? April 14, 20263:57 PM ET Heard o...
CitrixNews Staff
·
11 minutes ago
Politics
51 Percent of Americans Think Trump’s Military Action in Iran Has Not Been Worthwhile
A survey from Ipsos and Reuters, released on Tuesday, found few Americans — 24 percent — think the war in Iran has been ...
CitrixNews Staff
·
33 minutes ago
Politics
Gallego: ‘I deeply regret’ Swalwell relationship, ‘I was wrong’
Sen. Ruben Gallego (D-Ariz.) expressed regret on Tuesday for his friendship with Rep. Eric Swalwell (D-Calif.) and denie...
CitrixNews Staff
·
41 minutes ago
Politics
Senate Republicans plan to vote next week on budget plan to fund ICE, Border Patrol
Senate Majority Leader John Thune (R-S.D.) told reporters Tuesday that he plans to bring a budget resolution to the Sena...
CitrixNews Staff
·
46 minutes ago